Stocks · Healthcare · Medical - Devices
ClearPoint Neuro, Inc. CLPT
$10.90 -4.80% Close, Oct 2, 2026 · NASDAQ · Market cap $326.7M
Weak trend
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The stock is 63% below its highest close of the past year.
- Over the past year the stock returned -47.9%, behind the S&P 500 by 62.9 percentage points.
- Revenue over the last four quarters was $42.3M, up 25.9% from a year earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 27%
- Revenue growth, 3-year CAGRTop 28%
- Revenue growth accelerationTop 49%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 33%
- Gross marginBottom 48%
- Operating marginBottom 32%
- Accruals (lower is better)Bottom 43%
- Interest coverBottom 36%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 44%
- Free-cash-flow yieldBottom 38%
- EBITDA / enterprise valueBottom 44%
- Sales / enterprise valueBottom 35%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 16%
- 6-month returnTop 43%
- 1-year return vs S&P 500Bottom 11%
- Distance from 52-week highBottom 13%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 21%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetTop 34%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 14%
- Maximum drawdown, 3 yearsBottom 49%
- Beta vs S&P 500 (lower is better)Bottom 22%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 26.0% | 25.9% | ↓ |
| Gross margin | 60.4% | 62.6% | ↑ |
| Operating margin | -67.3% | -73.4% | ↓ |
| FCF margin | -34.9% | -74.0% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 25.9% | 26.0% | ↓ | Top 27% |
| Gross margin | 62.6% | 60.4% | ↑ | Bottom 48% |
| Operating margin | -73.4% | -67.3% | ↓ | Bottom 32% |
| Net margin | -81.8% | -66.2% | ↓ | — |
| Free-cash-flow margin | -74.0% | -34.9% | ↓ | — |
| Return on invested capital | -40.5% | — | Bottom 33% | |
| Revenue growth, 3-year CAGR | 21.6% | — | Top 28% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -5.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 20.1%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +93.7 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -7.7×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.45%
- Shareholder yield
- -0.45%
- Share count change, 1 year
- +5.7%
- Share count change, 3-year CAGR
- +6.7%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 3, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 0 of 8
- Average EPS surprise, last 4
- -18.6%
- Average 2-day reaction, last 8
- +1.8%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $23.50
- Target vs current price
- +115.6%
- Analysts with a rating
- 3
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 3, 2026 | -32.6% | +2.9% | -4.9% | +4.1% | — |
| May 13, 2026 | -14.3% | -3.6% | -11.6% | +8.8% | +12.4% |
| Mar 17, 2026 | -22.7% | +1.2% | -13.8% | -5.9% | +24.7% |
| Nov 6, 2025 | -5.0% | +7.4% | -1.6% | -17.2% | -17.9% |
| Aug 12, 2025 | -5.0% | -0.6% | +5.8% | +3.3% | +65.3% |
| May 13, 2025 | -46.7% | +4.1% | -3.8% | -2.6% | -19.9% |
| Feb 26, 2025 | -33.3% | +3.0% | -19.8% | -21.2% | -27.3% |
| Nov 7, 2024 | -5.9% | +0.3% | -18.2% | -5.7% | +40.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 3, 2026 | -$0.38 | -$0.29 | -32.6% | $10.9M |
| May 13, 2026 | -$0.32 | -$0.28 | -14.3% | $12.1M |
| Mar 17, 2026 | -$0.27 | -$0.22 | -22.7% | $10.4M |
| Nov 6, 2025 | -$0.21 | -$0.20 | -5.0% | $8.9M |
| Aug 12, 2025 | -$0.21 | -$0.20 | -5.0% | $9.2M |
| May 13, 2025 | -$0.22 | -$0.15 | -46.7% | $8.5M |
| Feb 26, 2025 | -$0.20 | -$0.15 | -33.3% | $7.8M |
| Nov 7, 2024 | -$0.18 | -$0.17 | -5.9% | $8.1M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 8.55× | — | — | Bottom 35% |
| Free-cash-flow yield | -9.58% | — | — | Bottom 38% |
| Earnings yield | -10.83% | — | — | Bottom 44% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -8.3%
- 200-day average slope (20 days)
- -0.1%
- Distance from 50-day average
- -24.2%
- Distance from 200-day average
- -18.7%
- RSI (14)
- 32.9
- Relative volume
- 1.15×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 85.7%
- Volatility vs own 5-year history
- 75th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.75
- Correlation with S&P 500
- 0.26
- Current drawdown from 1-year high
- -63.2%
- Maximum drawdown, 3 years
- -70.7%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 16, 2021 | Nov 10, 2023 | -84.6% | 690 days | 477 days (Oct 8, 2025) |
| Oct 8, 2025 | Mar 30, 2026 | -70.7% | 118 days | Not yet recovered |
| Oct 16, 2020 | Nov 4, 2020 | -19.5% | 13 days | 7 days (Nov 13, 2020) |
| Sep 28, 2020 | Oct 1, 2020 | -13.1% | 3 days | 9 days (Oct 14, 2020) |
| Dec 11, 2020 | Dec 15, 2020 | -10.8% | 2 days | 1 days (Dec 16, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $326.7M
- EPS, diluted (TTM)
- -$1.18
- Revenue (TTM)
- $42.3M
- 52-week range
- $8.27 – $30.10
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $16.3M | $20.6M | $24.0M | $31.4M | $37.0M |
| Gross profit | $11.1M | $13.5M | $13.6M | $19.1M | $22.7M |
| Operating income | -$13.4M | -$16.3M | -$22.4M | -$19.7M | -$24.2M |
| Net income | -$14.4M | -$16.4M | -$22.1M | -$18.9M | -$25.5M |
| EPS (diluted) | -$0.69 | -$0.68 | -$0.90 | -$0.70 | -$0.90 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.1M | $7.8M | $8.5M | $9.2M | $8.9M | $10.4M | $12.1M | $10.9M |
| Net income | -$5.0M | -$5.4M | -$6.0M | -$5.8M | -$5.9M | -$7.8M | -$9.6M | -$11.3M |
| EPS (diluted) | -$0.18 | -$0.20 | -$0.22 | -$0.21 | -$0.21 | -$0.27 | -$0.32 | -$0.38 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$12.7M | -$16.2M | -$13.7M | -$8.9M | -$23.9M |
| Capital expenditure | -$168,000 | -$253,000 | -$717,000 | -$275,000 | -$522,000 |
| Free cash flow | -$12.9M | -$16.4M | -$14.4M | -$9.2M | -$24.4M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $46.8M | $745,000 | -$210,000 | $16.1M | $3.9M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $29.4M
- Total assets
- $86.7M
- Total liabilities
- $76.0M
- Total debt
- $63.9M
- Net debt
- $34.6M
- Shareholders’ equity
- $10.8M
As of Jun 30, 2026 (filed Aug 3, 2026).
Short interest
- Shares sold short
- 4,329,777
- Days to cover
- 6.92
- Change vs previous report
- +3.3%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jul 27, 2016
- 1-for-40